A look behind the scenes into the planning of the AACR Annual Meeting, including the scientific program, conference logistics,...
Guest Post by Cynthia Ryan, PhD Past Mentor in the AACR’s Scientist↔Survivor Program (SSP)
Researchers have well established that smoking leads to adverse outcomes in cancer patients; however, the specific effects caused by...
Cancer immunotherapy refers to treatments that can unleash the power of a patient’s immune system to fight his or...
As more people are surviving cancer, there’s growing concern about how to care for their needs and improve long-term...
On June 1, the U.S. Food and Drug Administration (FDA) approved a liquid biopsy test, a companion diagnostic test...
As a physician-scientist specializing in melanoma, Yvonne Saenger, MD, applies her frequent interactions with patients to her research and...
For the first time, the American Association for Cancer Research invited three cancer advocates from the AACR Scientist↔Survivor Program...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of cancer types for which immunotherapeutics known...
With warm weather finally here, bringing more people outdoors, it is important to remember that many cases of skin...
AACR President Nancy E. Davidson, MD, discusses her goals for her Presidential year at the AACR in an editorial...